Created in 2008 (Germany), Neupro 8mg own 359 sister brands and 2214 competing brands. Neupro 8mg is a brand of UCB, listed on the stock exchange of Bruxelles. The International Securities Identification Number (ISIN) of UCB is BE0003739530. Neupro 8mg belongs to the Biotechnology business sector.

Neupro 8mg is a brand of UCB (UCB) Share price

Share price and profitability of the share UCB (Neupro 8mg)

Buy UCB share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 114.40

Portfolio valuation
UCB (Neupro 8mg) over 5 years* EUR 168.97

Stock market history UCB (Neupro 8mg)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more